Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

TG Therapeutics Price to Sales Ratio 2011-2025 | TGTX

Historical PS ratio values for TG Therapeutics (TGTX) over the last 10 years. The current P/S ratio for TG Therapeutics as of November 12, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
TG Therapeutics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-11-12 31.01 9.43
2025-09-30 36.13 $3.29 10.98
2025-06-30 35.99 $2.81 12.82
2025-03-31 39.43 $2.40 16.43
2024-12-31 30.10 $2.09 14.39
2024-09-30 23.39 $1.71 13.65
2024-06-30 17.79 $2.25 7.89
2024-03-31 15.21 $1.91 7.97
2023-12-31 17.08 $1.53 11.17
2023-09-30 8.36 $1.23 6.78
2023-06-30 24.84 $0.17 145.69
2023-03-31 15.04 $0.06 245.30
2022-12-31 11.83 $0.02 571.50
2022-09-30 5.92 $0.04 157.21
2022-06-30 4.25 $0.05 81.26
2022-03-31 9.51 $0.06 159.59
2021-12-31 19.00 $0.05 375.48
2021-09-30 33.28 $0.03 997.08
2021-06-30 38.79 $0.02 2112.91
2021-03-31 48.20 $0.01 0.00
2020-12-31 52.02 $0.00 0.00
2020-09-30 26.76 $0.00 0.00
2020-06-30 19.48 $0.00 0.00
2020-03-31 9.84 $0.00 0.00
2019-12-31 11.10 $0.00 0.00
2019-09-30 5.62 $0.00 0.00
2019-06-30 8.65 $0.00 0.00
2019-03-31 8.04 $0.00 0.00
2018-12-31 4.10 $0.00 0.00
2018-09-30 5.60 $0.00 0.00
2018-06-30 13.15 $0.00 0.00
2018-03-31 14.20 $0.00 0.00
2017-12-31 8.20 $0.00 0.00
2017-09-30 11.85 $0.00 0.00
2017-06-30 10.05 $0.00 0.00
2017-03-31 11.65 $0.00 0.00
2016-12-31 4.65 $0.00 0.00
2016-09-30 7.74 $0.00 0.00
2016-06-30 6.06 $0.00 0.00
2016-03-31 8.52 $0.00 0.00
2015-12-31 11.93 $0.00 0.00
2015-09-30 10.08 $0.00 0.00
2015-06-30 16.59 $0.00 0.00
2015-03-31 15.48 $0.00 0.00
2014-12-31 15.84 $0.00 0.00
2014-09-30 10.67 $0.01 0.00
2014-06-30 9.39 $0.01 0.00
2014-03-31 6.90 $0.01 0.00
2013-12-31 3.90 $0.01 0.00
2013-09-30 5.04 $0.00 0.00
2013-06-30 6.39 $0.00 0.00
2013-03-31 5.40 $0.00 0.00
2012-12-31 3.64 0 0.00
2012-09-30 2.25 0 0.00
2012-06-30 6.25 0 0.00
2012-03-31 6.75 0 0.00
2011-12-31 1.14 0 0.00
2011-09-30 6.19 0 0.00
2011-06-30 15.47 0 0.00
2011-03-31 39.38 0 0.00
2010-12-31 50.63 0 0.00
2010-09-30 84.38 0 0.00
2010-06-30 126.56 0 0.00
2010-03-31 236.25 0 0.00
2009-12-31 210.94 0 0.00
2009-09-30 267.19 0 0.00
2009-06-30 295.31 0 0.00
2009-03-31 59.06 0 0.00
2008-12-31 22.50 0 0.00
2008-09-30 253.13 0 0.00
2008-06-30 393.75 0 0.00
2008-03-31 450.00 0 0.00
2007-12-31 253.13 0 0.00
2007-09-30 646.88 0 0.00
2007-06-30 2221.88 0 0.00
2007-03-31 2531.25 0 0.00
2006-12-31 2165.62 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.939B $0.329B
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $276.304B 19.50
Amgen (AMGN) United States $182.249B 15.48
Gilead Sciences (GILD) United States $152.058B 14.97
Vertex Pharmaceuticals (VRTX) United States $108.901B 28.03
Bristol Myers Squibb (BMY) United States $99.182B 7.43
GSK (GSK) United Kingdom $98.292B 10.93
Regeneron Pharmaceuticals (REGN) United States $70.895B 18.39
Alnylam Pharmaceuticals (ALNY) United States $59.709B 1965.00
CSL (CSLLY) Australia $56.394B 0.00
Argenex SE (ARGX) Netherlands $54.774B 68.01
Insmed (INSM) United States $41.309B 0.00
Novozymes (NVZMY) Denmark $30.912B 0.00
BioNTech SE (BNTX) Germany $26.125B 0.00
Biogen (BIIB) United States $23.408B 9.53
Royalty Pharma (RPRX) United States $22.720B 8.62
Incyte (INCY) United States $21.234B 20.33
Genmab (GMAB) Denmark $19.461B 14.64
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.733B 28.12
Roivant Sciences (ROIV) United Kingdom $14.272B 0.00
Exact Sciences (EXAS) United States $12.789B 355.26
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.411B 0.00
Revolution Medicines (RVMD) United States $12.388B 0.00
Guardant Health (GH) United States $12.315B 0.00
Exelixis (EXEL) United States $11.522B 18.44
Avidity Biosciences (RNA) United States $10.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.553B 19.14
Moderna (MRNA) United States $10.318B 0.00
QIAGEN (QGEN) Netherlands $9.830B 18.66
Bio-Techne Corp (TECH) United States $9.221B 34.41
Repligen (RGEN) United States $8.637B 92.43
Abivax SA (ABVX) France $8.488B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.332B 32.49
Halozyme Therapeutics (HALO) United States $8.247B 13.18
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Cytokinetics (CYTK) United States $8.131B 0.00
Metsera (MTSR) United States $7.455B 0.00
Merus (MRUS) Netherlands $7.242B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.190B 0.00
Axsome Therapeutics (AXSM) United States $7.038B 0.00
Nuvalent (NUVL) United States $6.991B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.664B 0.00
Vaxcyte (PCVX) United States $5.977B 0.00
PTC Therapeutics (PTCT) United States $5.927B 8.05
Legend Biotech (LEGN) United States $5.912B 0.00
Krystal Biotech (KRYS) United States $5.887B 30.43
Arrowhead Pharmaceuticals (ARWR) United States $5.738B 0.00
Alkermes (ALKS) Ireland $5.583B 16.41
Protagonist Therapeutics (PTGX) United States $5.349B 138.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.262B 0.00
Arcellx (ACLX) United States $5.217B 0.00
Zealand Pharma (ZLDPF) Denmark $5.205B 5.15
Cogent Biosciences (COGT) United States $4.758B 0.00
Praxis Precision Medicines (PRAX) United States $4.590B 0.00
Viking Therapeutics (VKTX) United States $4.589B 0.00
Kymera Therapeutics (KYMR) United States $4.559B 0.00
Akero Therapeutics (AKRO) United States $4.466B 0.00
Ligand Pharmaceuticals (LGND) United States $4.108B 100.82
ACADIA Pharmaceuticals (ACAD) United States $4.013B 33.89
Immunovant (IMVT) United States $4.012B 0.00
ADMA Biologics Inc (ADMA) United States $3.825B 27.17
Mineralys Therapeutics (MLYS) United States $3.728B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.665B 0.00
Telix Pharmaceuticals (TLX) Australia $3.463B 0.00
Cidara Therapeutics (CDTX) United States $3.401B 0.00
Belite Bio (BLTE) United States $3.367B 0.00
Celcuity (CELC) United States $3.359B 0.00
Anbio Biotechnology (NNNN) Germany $3.328B 0.00
Travere Therapeutics (TVTX) United States $3.231B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.211B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.208B 0.00
Jyong Biotech (MENS) Taiwan $3.091B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.085B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.075B 90.16
GRAIL (GRAL) United States $3.006B 0.00
Disc Medicine (IRON) United States $2.992B 0.00
Ascentage Pharma Group - (AAPG) China $2.990B 0.00
CG Oncology (CGON) United States $2.961B 0.00
Scholar Rock Holding (SRRK) United States $2.960B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.943B 0.00
Apogee Therapeutics (APGE) United States $2.903B 0.00
Amicus Therapeutics (FOLD) United States $2.876B 233.00
IDEAYA Biosciences (IDYA) United States $2.806B 0.00
Viridian Therapeutics (VRDN) United States $2.713B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.658B 0.00
Denali Therapeutics (DNLI) United States $2.578B 0.00
Agios Pharmaceuticals (AGIO) United States $2.558B 0.00
Apellis Pharmaceuticals (APLS) United States $2.469B 62.94
Zai Lab (ZLAB) China $2.459B 0.00
Liquidia (LQDA) United States $2.417B 0.00
Bavarian Nordic (BVNRY) Denmark $2.327B 11.25
Beam Therapeutics (BEAM) United States $2.281B 0.00
Edgewise Therapeutics (EWTX) United States $2.274B 0.00
Adaptive Biotechnologies (ADPT) United States $2.218B 0.00
Arcus Biosciences (RCUS) United States $2.191B 0.00
ImmunityBio (IBRX) United States $2.108B 0.00
Vericel (VCEL) United States $2.076B 171.04
Recursion Pharmaceuticals (RXRX) United States $2.045B 0.00
Structure Therapeutics (GPCR) United States $2.008B 0.00
Mesoblast (MESO) Australia $1.992B 0.00
ANI Pharmaceuticals (ANIP) United States $1.921B 15.43
UniQure (QURE) Netherlands $1.921B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.900B 10.37
Vera Therapeutics (VERA) United States $1.896B 0.00
Twist Bioscience (TWST) United States $1.891B 0.00
Sarepta Therapeutics (SRPT) United States $1.884B 0.00
Terns Pharmaceuticals (TERN) United States $1.854B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.774B 0.00
Janux Therapeutics (JANX) United States $1.736B 0.00
Nuvation Bio (NUVB) United States $1.707B 0.00
Alvotech (ALVO) Luxembourg $1.682B 12.68
Sionna Therapeutics (SION) United States $1.627B 0.00
Celldex Therapeutics (CLDX) United States $1.619B 0.00
MannKind (MNKD) United States $1.612B 52.50
Immunome (IMNM) United States $1.607B 0.00
Maze Therapeutics (MAZE) United States $1.552B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.541B 0.00
Zenas BioPharma (ZBIO) United States $1.482B 0.00
Trevi Therapeutics (TRVI) United States $1.474B 0.00
Zymeworks (ZYME) United States $1.473B 0.00
Stoke Therapeutics (STOK) United States $1.434B 37.48
Spyre Therapeutics (SYRE) United States $1.410B 0.00
Certara (CERT) United States $1.367B 25.24
NeoGenomics (NEO) United States $1.348B 0.00
NovoCure (NVCR) Jersey $1.328B 0.00
Dynavax Technologies (DVAX) United States $1.323B 38.86
Upstream Bio (UPB) United States $1.285B 0.00
Pharvaris (PHVS) Netherlands $1.261B 0.00
Oric Pharmaceuticals (ORIC) United States $1.251B 0.00
WAVE Life Sciences (WVE) Singapore $1.214B 0.00
Novavax (NVAX) United States $1.209B 3.07
AbCellera Biologics (ABCL) Canada $1.200B 0.00
CureVac (CVAC) Germany $1.185B 5.50
Precigen (PGEN) United States $1.180B 0.00
Intellia Therapeutics (NTLA) United States $1.179B 0.00
Dianthus Therapeutics (DNTH) United States $1.162B 0.00
Sana Biotechnology (SANA) United States $1.129B 0.00
Tango Therapeutics (TNGX) United States $1.128B 0.00
Inhibrx Biosciences (INBX) United States $1.128B 0.00
Immatics (IMTX) Germany $1.117B 0.00
MiMedx (MDXG) United States $1.117B 19.84
Urogen Pharma (URGN) United States $1.106B 0.00
Fortrea Holdings (FTRE) United States $1.089B 23.12
Pharming Group (PHAR) Netherlands $1.082B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.064B 0.00
Iovance Biotherapeutics (IOVA) United States $1.052B 0.00
Pacira BioSciences (PCRX) United States $1.038B 11.88
Kodiak Sciences (KOD) United States $1.037B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Phathom Pharmaceuticals (PHAT) United States $1.022B 0.00
Castle Biosciences (CSTL) United States $1.021B 139.88
Oculis Holding AG (OCS) Switzerland $1.016B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $1.010B 0.00
Nanobiotix S.A - (NBTX) France $1.003B 0.00
Nurix Therapeutics (NRIX) United States $0.989B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.964B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.950B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.932B 44.75
Rezolute (RZLT) United States $0.931B 0.00
BGM Group (BGM) China $0.931B 0.00
Rapport Therapeutics (RAPP) United States $0.931B 0.00
Kura Oncology (KURA) United States $0.930B 0.00
AnaptysBio (ANAB) United States $0.929B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Arbutus Biopharma (ABUS) United States $0.903B 0.00
Biohaven (BHVN) United States $0.902B 0.00
CorMedix Inc (CRMD) United States $0.877B 14.92
Septerna (SEPN) United States $0.861B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.837B 0.00
LENZ Therapeutics (LENZ) United States $0.828B 0.00
Tyra Biosciences (TYRA) United States $0.808B 0.00
Bicara Therapeutics (BCAX) United States $0.807B 0.00
ArriVent BioPharma (AVBP) United States $0.800B 0.00
Geron (GERN) United States $0.798B 0.00
Vir Biotechnology (VIR) United States $0.794B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.772B 100.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.755B 0.00
GH Research (GHRS) Ireland $0.740B 0.00
Arvinas (ARVN) United States $0.720B 0.00
Replimune (REPL) United States $0.716B 0.00
MeiraGTx Holdings (MGTX) United States $0.716B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
CytomX Therapeutics (CTMX) United States $0.695B 10.25
Ventyx Biosciences (VTYX) United States $0.673B 0.00
Erasca (ERAS) United States $0.669B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Compass Therapeutics (CMPX) United States $0.640B 0.00
MapLight Therapeutics (MPLT) $0.624B 0.00
Myriad Genetics (MYGN) United States $0.623B 0.00
Cytek Biosciences (CTKB) United States $0.612B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.610B 0.00
Gossamer Bio (GOSS) United States $0.599B 0.00
Anavex Life Sciences (AVXL) United States $0.588B 0.00
REGENXBIO (RGNX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Emergent Biosolutions (EBS) United States $0.571B 5.49
Niagen Bioscience (NAGE) United States $0.571B 44.75
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Verastem (VSTM) United States $0.564B 0.00
Prothena (PRTA) Ireland $0.564B 0.00
Olema Pharmaceuticals (OLMA) United States $0.562B 0.00
Alumis (ALMS) United States $0.552B 0.00
Inventiva S.A (IVA) France $0.539B 0.00
Prime Medicine (PRME) United States $0.528B 0.00
Absci (ABSI) United States $0.516B 0.00
Keros Therapeutics (KROS) United States $0.515B 10.97
Monopar Therapeutics (MNPR) United States $0.515B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.501B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.492B 0.00
NovaBridge Biosciences (NBP) United States $0.488B 0.00
Rapt Therapeutics (RAPT) United States $0.488B 0.00
Eton Pharmaceuticals (ETON) United States $0.474B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.473B 0.00
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Neumora Therapeutics (NMRA) United States $0.459B 0.00
EnGene Holdings (ENGN) Canada $0.452B 0.00
DBV Technologies S.A (DBVT) France $0.451B 0.00
Design Therapeutics (DSGN) United States $0.442B 0.00
Fulcrum Therapeutics (FULC) United States $0.441B 0.00
Neurogene (NGNE) United States $0.441B 0.00
Bright Minds Biosciences (DRUG) United States $0.417B 0.00
XOMA Royalty (XOMA) United States $0.417B 0.00
Ocugen (OCGN) United States $0.415B 0.00
Kamada (KMDA) Israel $0.406B 19.61
LB Pharmaceuticals Inc (LBRX) United States $0.404B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.399B 0.00
PureTech Health (PRTC) United States $0.395B 0.00
Invivyd (IVVD) United States $0.385B 0.00
Northwest Biotherapeutics (NWBO) United States $0.368B 0.00
Alto Neuroscience (ANRO) United States $0.363B 0.00
Annexon (ANNX) United States $0.355B 0.00
Tectonic Therapeutic (TECX) United States $0.355B 0.00
Solid Biosciences (SLDB) United States $0.353B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.352B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
AC Immune (ACIU) Switzerland $0.340B 0.00
Amarin (AMRN) Ireland $0.333B 0.00
DiaMedica Therapeutics (DMAC) United States $0.330B 0.00
Contineum Therapeutics (CTNM) United States $0.320B 0.00
Jade Biosciences (JBIO) United States $0.320B 0.00
Kyverna Therapeutics (KYTX) United States $0.303B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.297B 0.00
Entrada Therapeutics (TRDA) United States $0.294B 0.00
Lifecore Biomedical (LFCR) United States $0.290B 0.00
Zura Bio (ZURA) United States $0.287B 0.00
BioAge Labs (BIOA) United States $0.281B 0.00
Immuneering (IMRX) United States $0.280B 0.00
Allogene Therapeutics (ALLO) United States $0.279B 0.00
Sagimet Biosciences (SGMT) United States $0.276B 0.00
Candel Therapeutics (CADL) United States $0.276B 0.00
Palisade Bio (PALI) United States $0.271B 0.00
Atea Pharmaceuticals (AVIR) United States $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.263B 12.83
Alpha Teknova (TKNO) United States $0.262B 0.00
Prima BioMed (IMMP) Australia $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.262B 7.01
Editas Medicine (EDIT) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.251B 0.00
Aardvark Therapeutics (AARD) United States $0.240B 0.00
Cabaletta Bio (CABA) United States $0.238B 0.00
Voyager Therapeutics (VYGR) United States $0.237B 0.00
Tenaya Therapeutics (TNYA) United States $0.236B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.235B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.235B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.232B 0.00
Genelux (GNLX) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
Adherex Technologies (FENC) United States $0.223B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.218B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.214B 4.53
Nautilus Biotechnology (NAUT) United States $0.210B 0.00
Caribou Biosciences (CRBU) United States $0.209B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.203B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Humacyte (HUMA) United States $0.203B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Cartesian Therapeutics (RNAC) United States $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.189B 0.00
Crescent Biopharma (CBIO) United States $0.184B 0.00
C4 Therapeutics (CCCC) United States $0.177B 0.00
Forte Biosciences (FBRX) United States $0.175B 0.00
Sangamo Therapeutics (SGMO) United States $0.169B 0.00
MaxCyte (MXCT) United States $0.165B 0.00
Coherus Oncology (CHRS) United States $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Codexis (CDXS) United States $0.163B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.155B 0.00
Cognition Therapeutics (CGTX) United States $0.154B 0.00
Cardiff Oncology (CRDF) United States $0.154B 0.00
Compugen (CGEN) Israel $0.153B 0.00
PepGen (PEPG) United States $0.153B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.151B 0.00
Alector (ALEC) United States $0.148B 0.00
Spero Therapeutics (SPRO) United States $0.147B 0.00
Anika Therapeutics (ANIK) United States $0.146B 0.00
Agenus (AGEN) United States $0.145B 0.00
Actuate Therapeutics (ACTU) United States $0.144B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Nkarta (NKTX) United States $0.143B 0.00
Rani Therapeutics Holdings (RANI) United States $0.139B 0.00
Entera Bio (ENTX) Israel $0.137B 0.00
Seres Therapeutics (MCRB) United States $0.135B 0.00
Applied Therapeutics (APLT) United States $0.133B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
Fate Therapeutics (FATE) United States $0.129B 0.00
Opus Genetics (IRD) United States $0.128B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.128B 0.00
EXoZymes (EXOZ) United States $0.127B 0.00
VistaGen Therapeutics (VTGN) United States $0.124B 0.00
TuHURA Biosciences (HURA) United States $0.122B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.119B 0.00
Greenwich LifeSciences (GLSI) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.115B 0.00
Citius Oncology (CTOR) United States $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
InflaRx (IFRX) Germany $0.111B 0.00
Turn Therapeutics (TTRX) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.108B 0.00
Oncolytics Biotech (ONCY) Canada $0.108B 0.00
Inovio Pharmaceuticals (INO) United States $0.107B 0.00
Instil Bio (TIL) United States $0.106B 0.00
Whitehawk Therapeutics (WHWK) United States $0.105B 0.00
OKYO Pharma (OKYO) $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.103B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.100B 0.00
Biomea Fusion (BMEA) United States $0.099B 0.00
Starpharma Holdings (SPHRY) Australia $0.098B 0.00
Clene (CLNN) United States $0.096B 0.00
Quince Therapeutics (QNCX) United States $0.096B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.096B 0.00
Ovid Therapeutics (OVID) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Kalaris Therapeutics (KLRS) United States $0.095B 0.00
Estrella Immunopharma (ESLA) United States $0.093B 0.00
Tevogen Bio Holdings (TVGN) United States $0.092B 0.00
XBiotech (XBIT) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Atara Biotherapeutics (ATRA) United States $0.088B 0.00
Artiva Biotherapeutics (ARTV) United States $0.088B 0.00
Chrome Holding (MEHCQ) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
CAMP4 Therapeutics (CAMP) United States $0.083B 0.00
Adagene (ADAG) China $0.080B 0.00
Fortress Biotech (FBIO) United States $0.080B 0.00
Precision BioSciences (DTIL) United States $0.080B 0.00
ATyr Pharma (ATYR) United States $0.077B 0.00
Immunic (IMUX) United States $0.077B 0.00
BioStem Technologies (BSEM) $0.077B 4.01
Repare Therapeutics (RPTX) Canada $0.074B 0.00
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
TScan Therapeutics (TCRX) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.069B 0.00
Vor Biopharma (VOR) $0.067B 0.00
CervoMed (CRVO) United States $0.064B 0.00
MiNK Therapeutics (INKT) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.060B 0.00
Equillium (EQ) United States $0.058B 0.00
Spruce Biosciences (SPRB) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Adicet Bio (ACET) United States $0.054B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
PDS Biotechnology (PDSB) United States $0.050B 0.00
Senti Biosciences (SNTI) United States $0.048B 0.00
TELA Bio (TELA) United States $0.047B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
CalciMedica (CALC) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Radiopharm Theranostics - (RADX) Australia $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
X4 Pharmaceuticals (XFOR) United States $0.040B 0.00
INmune Bio (INMB) United States $0.040B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
BioAtla (BCAB) United States $0.040B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Hyperion DeFi (HYPD) United States $0.039B 0.00
RenovoRx (RNXT) United States $0.039B 0.00
Generation Bio (GBIO) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Dyadic (DYAI) United States $0.035B 0.00
Elutia (ELUT) United States $0.035B 0.00
Rein Therapeutics (RNTX) United States $0.035B 0.00
ImageneBio (IMA) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Alterity Therapeutics - (ATHE) Australia $0.033B 0.00
BioXcel Therapeutics (BTAI) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Galecto (GLTO) Denmark $0.031B 0.00
Q32 Bio (QTTB) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Rallybio (RLYB) United States $0.030B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Jasper Therapeutics (JSPR) United States $0.028B 0.00
Synaptogenix (TAOX) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.025B 0.00
IBio (IBIO) United States $0.025B 0.00
Tharimmune (THAR) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
Intensity Therapeutics (INTS) United States $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Clearside Biomedical (CLSD) United States $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
MetaVia (MTVA) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
NewcelX (NCEL) Switzerland $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Apollomics (APLM) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
Longeveron (LGVN) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Cocrystal Pharma (COCP) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Imunon (IMNN) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Black Titan (BTTC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GT Biopharma (GTBP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Alps Group (ALPS) United States $0.002B 1.82
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00